BVS Bioventus Inc.

Bioventus is a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process. We believe our non-invasive medical device and biologic products play a critical role in supporting the body’s own healing mechanisms to heal or eliminate the pain caused by orthopedic conditions and problems, which we define as our active healing products.

$2.17  +0.22 (11.28%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  12/04/2014
Outstanding shares:  61,664,158
Average volume:  882,670
Market cap:   $120,245,108
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BD6P6L2
Valuation   (See tab for details)
PE ratio:   -7.14
PB ratio:   0.27
PS ratio:   0.26
Return on equity:   -3.74%
Net income %:   -3.61%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy